Literature DB >> 8417801

Human platelets secrete chemotactic activity for eosinophils.

J A Burgers1, R C Schweizer, L Koenderman, P L Bruijnzeel, J W Akkerman.   

Abstract

Thrombin-stimulated platelets liberate factors that induce chemotaxis of eosinophils and raise their cytosolic Ca2+ content ([Ca2+]i). The sources of this activity are the dense- and alpha-granules because inhibition of prostaglandin endoperoxide/thromboxane A2 formation and the platelet-activating factor receptor-antagonist WEB 2086 have no effect. Platelets from patients with Storage-Pool Deficiency show about 60% of the normal chemotactic activity with little effect on [Ca2+]i, whereas completely degranulated platelets fail to affect eosinophils. In concentrations secreted by the platelets, adenosine diphosphate (ADP), and platelet factor 4 have no effect, whereas adenosine triphosphate (ATP) induces a strong chemotactic response and increases [Ca2+]i. However, apart from ATP other modulating factors must be involved as platelet releasates induce more chemotaxis than ATP alone. Thus, platelets secrete factors that activate eosinophils and may contribute to inflammatory and allergic processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417801

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

2.  Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome.

Authors:  Alicja Kasperska-Zajac; Marek Nowakowski; Barbara Rogala
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

Review 3.  The eosinophil leukocyte: controversies of recruitment and function.

Authors:  L P Bignold
Journal:  Experientia       Date:  1995-04-15

4.  Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils.

Authors:  Marco Idzko; Elisabeth Panther; Hinrich C Bremer; Stephan Sorichter; Werner Luttmann; Christian J Virchow; Francesco Di Virgilio; Yared Herouy; Johannes Norgauer; Davide Ferrari
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 5.  Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.

Authors:  G Burnstock; A Verkhratsky
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

6.  Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin.

Authors:  P S Frenette; R C Johnson; R O Hynes; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

7.  Influence of nifedipine on plasma membrane fluidity and oxidative burst of polymorphonuclear leucocytes.

Authors:  W Grassi; R Serretti; P Core; S Muti; C Cervini
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

8.  E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.

Authors:  M M Teixeira; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 9.  Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.

Authors:  K Tajima; T Katagiri
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

10.  Chemotactic activity of extracellular nucleotideson human immune cells.

Authors:  Daniel Myrtek; Marco Idzko
Journal:  Purinergic Signal       Date:  2007-03-08       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.